Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Classical hematology 5Other hematologic neoplasm 2Sarcoma 1

Conditions

Leukemia, Myeloid, Acute 440Precursor Cell Lymphoblastic Leukemia-Lymphoma 238Hematologic Neoplasms 216Leukemia, Lymphocytic, Chronic, B-Cell 186Myelodysplastic Syndromes 160Leukemia 129Lymphoma 91Lymphoma, Non-Hodgkin 82Leukemia, Myelogenous, Chronic, BCR-ABL Positive 73Multiple Myeloma 69Recurrence 59Leukemia, Myelomonocytic, Chronic 56Neoplasms 53Leukemia, Biphenotypic, Acute 48Burkitt Lymphoma 48Myeloproliferative Disorders 46Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 43Lymphoma, Large B-Cell, Diffuse 42Lymphoma, Mantle-Cell 41Hodgkin Disease 39Lymphoma, Follicular 34Lymphoma, B-Cell 33Lymphoma, B-Cell, Marginal Zone 27Waldenstrom Macroglobulinemia 26Leukemia, B-Cell 26Anemia, Refractory, with Excess of Blasts 25Primary Myelofibrosis 24Myelodysplastic-Myeloproliferative Diseases 21Leukemia, Myeloid, Chronic-Phase 19Hematologic Diseases 19

Interventions

Vancomycin 1Teicoplanin 1Ofloxacin 1Metronidazole 1Meropenem 1Ciprofloxacin 1Ceftazidime 1Cefepime 1Amikacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Febrile Neutropenia × Other hematologic neoplasm × 90 days × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

NCT07277387 2026-04-23

Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia

Instituto de Investigación Biomédica de Salamanca

Not yet recruiting
350 enrolled
Classical hematologyOther hematologic neoplasm

Shock, Septic, Sepsis, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡